Secretin - EisaiAlternative Names: E 0286; Secrepan
Latest Information Update: 12 Jul 1995
At a glance
- Originator Eisai Co Ltd
- Class Antipsychotics; Gastrointestinal hormones; Neuropeptides; Peptide diagnostics; Peptide hormones
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Bleeding ulcer
Most Recent Events
- 12 Jul 1995 Discontinued-II for Bleeding ulcer in Japan (Unknown route)